← Eichor
Study identifier: NCT05969964 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Can Second Resection for pT1 Bladder Cancer be Avoided After Initial En-Bloc Resection With Negative Safety Margins

Condition: Bladder Cancer Stage I  ·  Sponsor: Mansoura University

PhaseN/A
Planned participants370
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this \[ Can second resection for pT1 bladder carcinoma be safely avoided after initial En-Bloc Resection with negative vertical and horizontal safety margins ? is to assess the impact of avoiding re TUR on Recurrence free survival, progression free survival and cancer specific survival in patients with pT1 bladder cancer treated with ERBT and intravesical BCG through a RCT.

This description comes directly from the study's public registry record.

Talk to the study team

Mahmoud Laymon, MD,MRCS  ·  01002275698  ·  dr_mahmoudlaymon@mans.edu.eg

Ahmed elassmy, MD  ·  a_assmy@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Urology and nephrology center, Mansoura UniversityAl Mansurah, Dakahlia Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05969964